Analysen von Michael Leuchten

09.12.20	AstraZeneca Neutral	UBS AG
30.11.20	AstraZeneca Neutral	UBS AG
23.11.20	AstraZeneca Sell	UBS AG
17.11.20	Merck Neutral	UBS AG
12.11.20	Merck Neutral	UBS AG
10.11.20	Roche buy	UBS AG
09.11.20	Novo Nordisk Neutral	UBS AG
09.11.20	Sartorius vz. Sell	UBS AG
Werbung
05.11.20	AstraZeneca Sell	UBS AG
03.11.20	Bayer buy	UBS AG
02.11.20	Novo Nordisk Neutral	UBS AG
30.10.20	Novo Nordisk Neutral	UBS AG
29.10.20	Roche buy	UBS AG
26.10.20	AstraZeneca Sell	UBS AG
26.10.20	Bayer buy	UBS AG
16.10.20	Roche buy	UBS AG
15.10.20	Roche buy	UBS AG
14.10.20	Bayer buy	UBS AG
09.10.20	Novo Nordisk Neutral	UBS AG
05.10.20	Bayer buy	UBS AG
01.10.20	Bayer buy	UBS AG
30.09.20	Roche buy	UBS AG
25.09.20	Novo Nordisk Neutral	UBS AG
18.09.20	Roche buy	UBS AG
09.09.20	AstraZeneca Sell	UBS AG
02.09.20	Roche buy	UBS AG
18.08.20	Novo Nordisk Neutral	UBS AG
11.08.20	Roche buy	UBS AG
07.08.20	Merck Neutral	UBS AG
06.08.20	Novo Nordisk Neutral	UBS AG
04.08.20	Bayer buy	UBS AG
31.07.20	Sartorius vz. Sell	UBS AG
30.07.20	Roche buy	UBS AG
27.07.20	Roche buy	UBS AG
23.07.20	Roche buy	UBS AG
22.07.20	Bayer buy	UBS AG
21.07.20	Sartorius vz. Sell	UBS AG
21.07.20	AstraZeneca Sell	UBS AG
20.07.20	Novo Nordisk Neutral	UBS AG
16.07.20	Sartorius vz. Sell	UBS AG
10.07.20	Bayer buy	UBS AG
09.07.20	Bayer buy	UBS AG
08.07.20	Bayer buy	UBS AG
01.07.20	Bayer buy	UBS AG
25.06.20	Sartorius vz. Sell	UBS AG
25.06.20	Bayer buy	UBS AG
23.06.20	Bayer buy	UBS AG
15.06.20	Bayer buy	UBS AG
10.06.20	Bayer buy	UBS AG
08.06.20	AstraZeneca Sell	UBS AG